A multicountry user experience analysis of e-TB Manager and an in-depth study in Ukraine were published. However, the procedural aspects of e-TB Manager implementation in each country were not documented. While facilitators and barriers for eHealth implementation in resource-constrained settings are well known, the objective of this paper is to summarize the tailored implementation approaches given local context, which is a crucial consideration. The paper summarizes the key lessons learned and implications for other electronic health information systems.
Project dates: September 2012 – June 2017
The availability of a unified essential medicines list (EML) with evidence-based clinical efficacy to be used by the Ministry of Health (MOH) for the state-guaranteed package of services is an essential part of the successful launch of the health care reform initiative in Ukraine. This required the development and institutionalization of a process to ensure sustainability into the future rather than a one-off list of essential medicines. The main task of SIAPS was the provision of technical assistance to the Government of Ukraine to solve the problem of medicines list harmonization, which was needed to review and update the NEML to be the sole list for procurement or reimbursement with public funds, and to develop legislative documentation to institutionalize the process. The work was performed in cooperation with the MOH and the State Expert Center.
On June 30, 2017, SIAPS closed its office in Ukraine. Since 2011, SIAPS worked with the Ministry of Health (MOH) and other stakeholders strengthening the country’s pharmaceutical systems and enhancing transparency of procurement practices and rational medicine use. SIAPS provided assistance to streamline medicine selection by harmonizing the essential medicines list (EML). This was done […]
Tuberculosis, which is the leading cause of death among infectious diseases in Ukraine, is especially dangerous due to the high estimated number of patients with multidrug-resistant TB. Since its implementation in 2008, e-TB Manager, a digital case management tool, has shown strong results: 81% of users, including doctors, nurses, and laboratory professionals, agree that it […]
Assessments conducted in 2013 on the management of TB drugs in Ukraine highlighted specific pharmaceutical management challenges, particularly in terms of data collection, capacity constraints, data quality, and frequency of reporting. Of note, cases of TB within the penitentiary system―roughly 15% of all TB cases in Ukraine―were poorly tracked; even when available, data from the penitentiary system were not integrated with the information system at the Ministry of Health (MOH), which skewed TB surveillance data. Furthermore, ongoing political unrest and personnel changes at the MOH continue to hinder efforts to address these challenges.
Konduri N, Lebega O. Analysis of medicines expenditure in ukraine: Implications for rational selection. E9 Short oral presentation, Part 2a (Practice & Education) at the 76th FIP World Congress of Pharmacy and Pharmaceutical Sciences 2016, Buenos Aires, Argentina. August 30, 2016.
In Ukraine in recent years, failed rounds of centralized public tenders for pharmaceuticals and blockage of public funds in antimonopoly litigations were regarded as a harbinger of the impending crisis in the public health sector. The Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program was requested to step in and provide technical assistance to improve the system of public pharmaceutical procurement and enhance the expertise of the selected regional health administrations and individual health care facilities. Framework contracting was viewed as the most effective procurement technique to ensure value for money in the contexts of decentralization and diverse regional specifics. SIAPS led the implementation of framework contracting into the oblast procurement practices in two oblasts, with the ultimate goal of bringing systemic changes into the national health procurement system.
When doctors and patients fail to adhere to proper standards of treatment, it results in a higher disease burden, including greater financial costs, mortality, and morbidity. In Ukraine, the need to encourage better adherence to standard treatment guidelines became clear in 2011, when a study by SIAPS Program’s predecessor, the Strengthening Pharmaceutical Systems (SPS) Program, […]
Ukraine has the second-highest burden of TB in the European region. According to the Ukraine’s Ministry of Health, TB is the leading cause of death from infectious diseases in the country. Ukraine’s efforts at TB control use a mix of standardized approaches, including Stop TB strategies, as well as directly observed therapy short-course (DOTS) guidelines […]
The primary goal of the SIAPS TB Core portfolio was to ensure the availability of quality pharmaceutical products and support […]
- Rapport de quantification des produits de la santé reproductive, maternelle, néonatale et infantile pour la période de janvier 2017 à décembre 2020
La présente activité avait pour objectif d’apporter un soutien au Ministère de la Santé et de l’Hygiène publique (MSHP) pour […]
Project dates: September 2012 – December 2016